Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine...

Molecular Cancer Therapeutics 2011 / 05 Vol. 10; Iss. 5

Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family

Brave, S. R., Ratcliffe, K., Wilson, Z., James, N. H., Ashton, S., Wainwright, A., Kendrew, J., Dudley, P., Broadbent, N., Sproat, G., Taylor, S., Barnes, C., Silva, J. C., Farnsworth, C. L., Hennequi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-10-0976
Date:
May, 2011
File:
PDF, 1.01 MB
english, 2011
Conversion to is in progress
Conversion to is failed